CMV management in a post-kidney-transplant child.
Elshihabi
I
I
Department of Pediatrics, University of Texas Health Science Center at San Antonio 78284-7813.
D003404:Creatinine / Q000097:blood; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy*; D015774:Ganciclovir / Q000008:administration & dosage; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007223:Infant; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology / Q000502:physiology
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D003404:Creatinine; D015774:Ganciclovir